AI Startup WellTheory Raises $14 Million From General Catalyst, Accel, 7wire Ventures To Transform Autoimmune Health For Millions Of Patients

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

WellTheory, a female-founded health technology startup utilizing artificial intelligence to transform autoimmune care, announced Tuesday that it secured $14 million in Series A funding. The round was led by General Catalyst, with participation from 7wire Ventures, Ingeborg Investments, Accel, Box Group, and Up2 Opportunity Fund.

WellTheory founder and CEO Ellen Rudolph launched the company in 2022 after spending years navigating her own autoimmune diagnosis and realizing how fragmented traditional care models had become.

Rudolph said the company’s mission is to “reimagine autoimmune care from the ground up” through holistic, personalized programs that address the root causes of each patient’s symptoms rather than treating them in isolation.

Don’t Miss:

According to the Autoimmune Association, more than 50 million Americans live with autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis, a number that has more than doubled over the past three decades.

The association added that the economic burden of autoimmune diseases is projected to reach $180 billion in 2025 across 29 major conditions, with costs expected to double within the next 15 years if new treatments do not emerge.

WellTheory says it treats patients with over 100 distinct autoimmune diagnoses using personalized care plans that adapt to each member’s symptoms and root causes, tailoring treatment to individual symptoms rather than diagnosis alone.

The company plans to expand its personalized digital platform, which utilizes proprietary AI tools, including Care Hub and Care Scribe, to streamline treatment plans and automate documentation. These systems help WellTheory’s care teams personalize support for patients with autoimmune conditions while improving efficiency across operations.

Members work with a human care team that includes a registered dietitian, a certified health coach, and a care coordinator through one-on-one sessions and unlimited messaging, WellTheory says.

Trending: If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?

WellTheory’s funding round holds deeper significance because all institutional investors involved were female partners, a rarity in venture capital where less than 2% of total funding goes to women-led startups, the company said.

Rudolph credited partners Candace Richardson and Holly Maloney from General Catalyst and Alyssa Jaffee and Tiffany Yu from 7wire Ventures in the statement for understanding the urgency of rebuilding healthcare systems that have often excluded women’s perspectives.

She said Richardson and Maloney understand the issue on a personal level, having witnessed how autoimmune conditions affect people close to them, a perspective that strengthened their resolve to drive meaningful change in healthcare.

Rudolph added that the collaboration feels like “building the system we’ve always deserved to see,” reflecting a shared goal of advancing equity in both patient care and entrepreneurship.

See Also: The ‘ChatGPT of Marketing’ Just Opened a $0.81/Share Round — 10,000+ Investors Are Already In

Over the past year, WellTheory said it expanded its reach through collaborations with major employers such as Maven Clinic, Fortune Brands Innovations, and Dayforce, along with health insurers including Sentara Health Plans, which serves more than 1 million members in Virginia and Florida.

Company data shows membership increased more than tenfold in the past 12 months, with revenue growing fivefold as organizations sought integrated autoimmune care solutions.

The new investment will support broader enterprise partnerships, expansion of the product and technology divisions, and continued development of WellTheory’s proprietary AI systems to enhance efficiency and personalization across its care network, the company said.

Read Next: Backed by $300M+ in Assets and Microsoft’s Climate Fund, Farmland LP Opens Vital Farmland III to Accredited Investors

Image: Shutterstock

This article AI Startup WellTheory Raises $14 Million From General Catalyst, Accel, 7wire Ventures To Transform Autoimmune Health For Millions Of Patients originally appeared on Benzinga.com